Foundation Venture Capital Group Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 4

Professionals

  • Investments
  • 22

  • Portfolio
  • 5

  • Exits
  • 13

Exits

Foundation Venture Capital Group General Information

Company Description

Founded in 2006, Foundation Venture Capital Group is a venture capital firm based in Princeton, New Jersey. The firm seeks to invests in the healthcare and health-related technology sectors.

Business Details

Year Founded
2006
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 155 Village Boulevard
  • Suite 130
  • Princeton, NJ 08540
  • United States

Foundation Venture Capital Group Investments (22)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
KayoThera 13-Jul-2023 Later Stage VC 000.00 Drug Discovery Generating Revenue 00000 0000000000
NemaGen Discoveries 16-Jul-2021 0000 00000 000 Drug Discovery Pre-Clinical Trials 000000 00000000 00
Durin Technologies 17-Dec-2019 00000 00000 00.00 Biotechnology Generating Revenue 00000 0000000000
OculoMotor Technologies 29-Jul-2019 0000 00000 00000 Diagnostic Equipment Generating Revenue 000000 00000000 00
KayoThera 03-Mar-2018 0000 00000 00000 Drug Discovery Generating Revenue 000000 00000000 00
Visikol 30-Dec-2017 00000 00000 Drug Discovery Generating Revenue 0000000 00000 00
Actinobac Biomed 12-Jul-2017 00000 00000 00.00 Pharmaceuticals Out of Business 00000 0000000000
DuelPrep 10-May-2017 0000 00000 Educational Software Out of Business
Visikol 23-Feb-2016 Seed Round 00000 Drug Discovery Generating Revenue 0000000 00000 00
NovoPedics 18-Apr-2013 Early Stage VC 00000 Therapeutic Devices Generating Revenue 00000 0000000000
You’re viewing 10 of 22 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Foundation Venture Capital Group Exits (13)

Company Name Exit Date Exit Type Exit Size
Celvive 03-Jan-2023 Out of Business
Actinobac Biomed 07-Jul-2022 000 00 00000000
Prolong Pharmaceuticals 01-Feb-2022 000000000 00000000
NovoPedics 01-Nov-2021 000000000 00000000
Visikol 20-May-2021 000000000000000000 00.00
Snowdon 19-Nov-2020 000 00 00000000
MentiNova 17-Nov-2020 000 00 00000000
GeneAssess 01-Jun-2019 000 00 00000000
Affinity Biologicals 01-Nov-2018 Merger/Acquisition
CellXplore 01-Sep-2018 Out of Business
You’re viewing 10 of 13 exits. Get the full list »

Foundation Venture Capital Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Foundation Venture Capital Group Management, Team & Partners (13)

Name Title Deals Funds Boards Office
George Heinrich MD Vice Chairman, Chief Executive Officer & Board Member 0 0 Princeton, NJ
James Golubieski President 00 0 Princeton, NJ
Scott Alpizar Director of Venture Commercialization Princeton, NJ
Joshua Tropper Venture Associate Princeton, NJ
Kelly Jeng Venture Associate Princeton, NJ
You’re viewing 5 of 13 team members. Get the full list »

Foundation Venture Capital Group Co-Investors (5)

Name With Exits Lead Partner Series Industry
7G Bioventures 1 0 Series chart Industry bar
Accelerator Life Science Partners 0 0 Series chart Industry bar
BioAdvance 0 0 Series chart Industry bar
Pier 70 Ventures 0 0 Series chart Industry bar
WRF Capital 0 0 Series chart Industry bar
To view Foundation Venture Capital Group’s complete co-investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »